by mroseboro | Mar 11, 2019 |
Qwixel Therapeutics addresses the need to develop therapeutics to treat multiple myeloma (MM), a B cell cancer disease that is not curable. Market:The anti-CD138 fused with Interferon (IFN) will both directly kill the malignant cells and will help boost the immune...
by mroseboro | Jan 17, 2019 |
Magnify The Next Generation Incubator KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s lead product, KYBELLA™, is the...
Recent Comments